Term
Medications that aggravate GI |
|
Definition
NSAIDS/Aspirin, Bisphosphonates, Iron, K Chloride |
|
|
Term
meds to enhance mucosal protection |
|
Definition
Sacralfate, Alainic acid, PGs |
|
|
Term
meds to enhance LES pressure |
|
Definition
Metoclopromide (Reglan), bethanechol |
|
|
Term
meds that enhance gastric emptying |
|
Definition
Prokinetics Metoclopromide (Reglan), Bethanechol |
|
|
Term
meds that inhibit gastric acid |
|
Definition
|
|
Term
|
Definition
-idines
MoA: inhibit His at H2-receptors of gastric parietal cells
Indications: symptomatic GERD, PUD, stress ulcer prophylaxis
-30-69 min prior to meals (except Cimetidine)
AE-mild, HA, diarrhea (except Cimetidine)
-Medications: Ranitidine (Zantac), Famotidine (Pepcid)
-Cimedtine (Tagament) |
|
|
Term
|
Definition
-H2RA
-can be taken immediately prior to meal and maintains efficacy
-AE-hormonal effects including gynecomastia, galactorrhea
DI-CYP 450 inhibitor |
|
|
Term
|
Definition
-prazole
MoA: suppress acid secretion by inhibiting parietal cell
-H+/K+ ATP (proton pump)
-uses: PUD, symptomatic GERD, hypersecretory syndromes
-better than H2RA's for healing of ulcers
-effects begin in 1-2 h, maximal effects may take days to weeks
-Meds: Omeprazole (Prilosec) -more DI than others
-Lansoprazole (Prevacid) |
|
|
Term
|
Definition
MoA-weak bases to neutralize gastric acid
common ingredients: Al (constipation), Mg (diarrhea), Ca, Na Bicarbonate
-combo of Al and MG to balance bowel effects
-Na-use caution in edematous states
-Al, Mg, Ca can accumulate in renal dysfunction |
|
|
Term
|
Definition
Sulcralfate (Carafate)
-forms gel with epithelium and makes a physical barrier
Bismuth Salicyclate (PeptoBismol)
-coating of epithelium and damaged tissue, decreases pepsin, increases protective mucus, antimicrobial actions
Use-dydpepsia, traveler's diarrhea, part of H. Pylori regiimen
AE-dark stools, black hairy tongue
Caution: salicylate allergy, febrile PED patient |
|
|
Term
|
Definition
1st line: 3 drug tx
-PPI + OMeprazole 20 mg BID
-Clarithromycin (Biaxin) 500 mg BID
-Amoxicillin 1 g BID or Metronidazole (Flagyl) 500 mg BID
-therapy usually lasts 14 days
-other approved regimens also |
|
|
Term
|
Definition
-Diphenhydrinate (Dramamine)-tx and prevention of N/V assoc. with motion-sickness or vertigo
-Anticholinergics:
-Scopolamine (Transderm Scop)-blocks Ach, dries secretions, antagonizes His and serotonin,for motion sickness (1 patch behind ears 4-12 hr before travel; replace q3d), opioids, and anesthesia; AE: anticholinergic and photosensitivity |
|
|
Term
|
Definition
-tx N/V
-MoA-block dopamine receptors
AE-extrapyramidal effects, sedation
drugs: chlorpromazine (Compazine), Promethazine (Phenergan)--also has anti-His activity (in PO and PR forms) |
|
|
Term
|
Definition
-Setron
-tx N/V
-block 5HT3 receptors in CNS and periphery (vagal fibers and CTZ)
-prevention of chemo-induced N/V, radiation induced N/V, post-op N/V
Meds: Ondansetron (Zofran), Ganisetron (Kytril), Dolasetron (Anzamet), Palonsetron (Aloxi) |
|
|
Term
Substance P/Neurokinin Inhibitor |
|
Definition
-tx N/V
-Aprepitant (Emend)-prevents acute and delayed N/V, augments serotonin blockers and corticosteroids |
|
|
Term
|
Definition
-tx N/V too assoc. with gastric acid
-H2RA
|
|
|
Term
|
Definition
-tx N/V with gastroparesis, alternative tx for PUD
-multiple MoA-blocks dopamine and serotonin receptors in CTZ, increases response to Ach in upper GI to cause enhanced motility and gastric emptying w/o stimulating secretions, increases LES tone
AE-movement d/o, diarrhea, drowsiness, CV effects
|
|
|
Term
Adsorbants/Hygroscopic agents |
|
Definition
-tx of diarrhea
-bulk-forming: polycarbophil (Fibercon)
-clay: kaolin pectin, Attapulgite
-binds certain bacteria and toxins, decreases water loss |
|
|
Term
|
Definition
tx of diarrhea
-opioid derivatives:
-Loperamide (Imodium)-inhibit peristalsis and prolong transit time, decrease fecal volume with increased viscosity, increase tone of anal sphincter
-Diphenoxylate.Atropine (Lomotil) |
|
|
Term
|
Definition
-tx of diarrhea
-Bismuth Subsalicylate (PeptoBismol)
-antisecretory and antimicrobial
-used for diarrhea-mild/nonspecific, Traveler's diarrhea (E.coli), part of H. pylori regimen |
|
|
Term
C. diff infectious diarrhea |
|
Definition
-assoc with antibiotic use (within 5-10 d)
2 hr up to 3 mo after antibiotics
tx: Metronidazole (Flagyl)
|
|
|
Term
Giardia infectious diarrhea |
|
Definition
assoc. with foreign travel and lake/pond water
tx: Metronidazole (Flagyl) |
|
|
Term
infectious diarrhea assoc with foreign travel |
|
Definition
tx: Ciprofloxacin or bismuth Subsalicylate (PeptoBismol) |
|
|
Term
Stimulant/Irritant laxatives |
|
Definition
-tx constipation
-MoA-secrete water/electrolytes into bowel; stimulate peristalsis in about 8-10 hr
AE: diarrhea, abdominal cramping, fluid/electrolyte abnl, dependence
-Senna (Senekot), Biscodyl (Dulcolax) |
|
|
Term
Saline/Osmotic Laxatives
Cathartics |
|
Definition
-tx constipation
-MoA-nonabsorbable salts hold water in bowel causing distention and increased bowel activity
-used for bowel-prep before procedures (effective in 1-6 h)
AE: bloating, diarrhea, cramping
-Mg Citrate, Na Phosphate, Polyethylene glycol (PEG), Lactulose |
|
|
Term
Miralax (Polyethylene Glycol 3350) Powder |
|
Definition
-osmotic laxative
-tx occasional constipation (different formula than bowel prep) |
|
|
Term
|
Definition
tx constipation
-MoA-facilitate passage of stools by lube
-AE-diarrhea, GI upset (mineral oil aspiration pneumon)
-drugs-mineral oil, glycerin suppositories |
|
|
Term
|
Definition
-tx constipation
-emulsify with stool producing softer stools (effects in 1-3 days)
-safe for regular or LT use--NO DEPENDENCE
-often used in conjunction with opioids to prevent constipation
-can take several days to show results
-Docusate Sodium (Colace) |
|
|
Term
|
Definition
-tx constipation
-MoA-indigestible compounds that accumulate in the bowel and draw water into the bowel
AE-constipation, bowel impaction, bloating, GI upset
-NOT assoc with dependence
-Psyllium, bran, methylcellulose
-effects in about 1-3 days |
|
|
Term
|
Definition
•Local Anesthetics
–Benzocaine
–Lidocaine (Xylocaine®)
–Pramoxine (Anusol®, Proctofoam®)
•Vasoconstrictors
–Phenylephrine
•Skin Protectants
–Aluminum Hydroxide, Cocoa Butter, Glycerin, Kaolin, Petrolatum, Shark liver oil
•Astringents
–MoA: temporarily tighten & soothe aching varicose veins or ¯ inflammation
–Witch hazel (Tucks®)
–Calamine
•Topical corticosteroids
–Hydrocortisone (Anusol HC®, Proctofoam HC®)
|
|
|
Term
|
Definition
-tx IBD
-MoA-modulation of local inflammatory mediators, scavenges free radicals and inhibits TNF
-meds:
-Sulfasalzine-sulfa antimicrobial activity; high AE; caution in sulfa allergy
-Mesalamine-site of action depends on product (rectum, colon, distal small bowel)
-AE-abdominal pain and possible worsening of symptomatic IBD with the initiation of therapy |
|
|
Term
Site of action of Aminosalicylates |
|
Definition
|
|
Term
|
Definition
-tx topically if possible with 5-ASA (colon, rectum, perianal)
-tx systemically with 5-ASA if topical tx is not possible or unsuccessful
-if systemic 5-ASA is ineffective, try systemic PO corticosteroids
-if PO ineffective, IV hydrocortisone
-if that uneffectice, then immunosuppresants and immunomodulators
-if pt has severe dz and continuous symptoms, put on IV fluids and hydrocortisone
-rectal corticosteroids available topically too |
|
|
Term
|
Definition
-non-selective BB (NSBB
-1st line tx to reduce portal HTN
-decrease bleeding and mortality in pts with varices
-start dose low and titrate to decrease HR by 25% or 55 bpm
-if HR goal isn't reached, think about adding a Nitrate
-Propanolol (Inderal), Nadolol (Corgard) |
|
|
Term
tx of cirrhosis and portal HTN |
|
Definition
-diuretics:
-Spironolactone (Aldactone)-aldosterone antagonist counteracts the effects of RAAS
-Furosemide (Lasix)-combo therapy req (Furosemide + Spironolactone)-ratio of 40 mg of Furosemide to 100 mg of Spironolactone to maintain a serum K in the nl range; wait at least 3 days in between dosages (ascites takes longer to equilibrate with vascular fluid than peripheral edema)
-target of ascites tx is 0.5L/qday
-maintain adequate excretion of Na
spot urine Na/K ratio greater than 1.0 |
|
|
Term
|
Definition
-tx variceal bleeding-control bleeding, prevent rebleeding, avoid acute complications, mortality of 1st episode is 55%
-octreotide-somatostain analog, decrease portal venous pressure by selective vasoconstriction of splanchnic bed, loading dose then hr infusions for 2-3 d, greatest risk of re-bleed within 1st 5 days, so therapy can cont that long
-antibiotic prophylaxis-recomended in acute variceal bleeding to decrease hospital-acquired infections (and mortality)
-use FQ or 3G Ceph |
|
|